Drug Eluting Stenting and Short Dual Antiplatelet Therapy for Preventing Recurrent Stroke in Vertebral Stenosis Registry Study

Not yet recruitingOBSERVATIONAL
Enrollment

520

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Vertebral Artery Stenosis
Interventions
DRUG

DAPT for 3 months after vertebral artery stenting

After implantation of a drug-eluting stent in the vertebral artery, dual antiplatelet therapy (DAPT) were administered for 3 months. The types of antiplatelet medications are not limited, with the standard regimen consisting of aspirin 100 mg once daily combined with either clopidogrel 75 mg once daily or ticagrelor 90 mg twice daily. Additional antiplatelet agents such as indobufen may also be considered acceptable.

Trial Locations (1)

Unknown

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06683300 - Drug Eluting Stenting and Short Dual Antiplatelet Therapy for Preventing Recurrent Stroke in Vertebral Stenosis Registry Study | Biotech Hunter | Biotech Hunter